Loading data for INDP — first visit, this takes a few seconds.
Indaptus Therapeutics Inc... (INDP)
NasdaqCM: INDP
· Precio en tiempo real · USD
1.07
+0.01 (0.94%)
Al cierre: Aug 14, 2026, 8:00 PM
Indaptus Therapeutics Inc. (INDP) Stock Price, Analysis & Data
0.94% (1D)
No hay datos disponibles
| Precio de compra | 0.78 |
| Capitalización de mercado | 142.57M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | -18.86M |
| Beta | 1.18 |
| EPS (TTM) | -12.7 |
| Ratio PER (TTM) | n/a |
| Adelante PE | -0.77 |
| P/B (TTM) | 97.27 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 1.34 |
| Volumen | 130,789 |
| Volumen medio (20D) | 1,032,104 |
| Abierto | 1.09 |
| Anterior Cerrar | 1.06 |
| Rango del día | 1.02 - 1.15 |
| Rango de 52 semanas | 0.92 - 8.57 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de INDP
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as f...
Industria Biotechnology
Sector Healthcare
IPO Fecha Aug 4, 2015
Empleados 5
Bolsa de Valores NasdaqCM
Símbolo bursátil INDP
Sitio web https://indaptusrx.com
Desempeño financiero
En 2025, los ingresos de Indaptus Therapeutics fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -20.85M, un aumento de 38.79%.
Estados financierosSorpresa de resultados
Indaptus Therapeutics ha publicado sus resultados trimestrales en Mar 17, 2026: